Target intelligence / Profile preview

P-glycoprotein (ABCB1) and ATP-binding cassette sub-family G member 2 (ABCG2) (P-gp; ABCG2)

Target
P-gp; ABCG2
Molecular classification
Transporter, ATP-binding cassette (ABC) transporter
01

Overview

P-glycoprotein and ABCG2 are integral membrane proteins that utilize ATP hydrolysis to actively transport a broad spectrum of structurally diverse substrates, including many drugs, from the intracellular to the extracellular space or into the lumen of cell organelles[1][2][3][5][7]. Both are part of the ABC transporter family, with P-glycoprotein being a full transporter composed of two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs), while ABCG2 is a half transporter functioning as a homodimer[4][5]. They are highly promiscuous in substrate recognition, often binding and moving multiple unrelated drugs. Over-expression of either transporter in cancer cells is a well-documented cause of multidrug resistance, limiting the effectiveness of many chemotherapeutic agents. Expression in normal tissues also restricts the absorption or tissue penetration of drugs, protecting sensitive tissues such as the brain.

Other names
Multidrug resistance protein 1MDR1ABCB1PGY1Breast Cancer Resistance ProteinBCRPCDw338
02

Mechanism of action

Drugs may act as substrates (transported out of the cell), inhibitors (blocking transporter function to increase intracellular drug accumulation), or modulators (altering transporter ATPase activity)

03

Biological functions

Drug effluxProtection of tissues by limiting xenobiotic entryMultidrug resistanceDetoxification
04

Disease associations

Cancer (promotes multidrug resistance)Gout (ABCG2 involvement)Other: Influences drug distribution and pharmacokinetics in various diseases
05

Safety considerations

Therapeutic challenges include drug resistance in cancer therapy due to efflux of anticancer drugs.Drug-drug interactions: Drugs that inhibit or are substrates of these transporters can cause altered pharmacokinetics or toxicity of co-administered medications.Tissue protection: Over-inhibition may disrupt physiological barriers (blood-brain or placental)
06

Interacting drugs

Anthracyclines (doxorubicin, daunorubicin)

8 more in the full profile.

07

Biomarkers

Expression levels of P-glycoprotein and ABCG2 in tumor or tissue samples are biomarkers for multidrug resistance, drug disposition, and treatment response

Beyond the preview

Go deeper on P-glycoprotein (ABCB1) and ATP-binding cassette sub-family G member 2 (ABCG2) (P-gp; ABCG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-glycoprotein (ABCB1) and ATP-binding cassette sub-family G member 2 (ABCG2) (P-gp; ABCG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call